NEOGENOMICS INC
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
| Table of Contents | NEOGENOMICS, INC. |
|---|
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: February 17, 2026 | NEOGENOMICS, INC. | |
|---|---|---|
| By: | /s/ Anthony P. Zook | |
| Name: | Anthony P. Zook | |
| Title: | Director and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signatures | Title(s) | Date |
|---|---|---|
| /s/ Anthony P. Zook | Director and Chief Executive Officer (Principal Executive Officer) | February 17, 2026 |
| Anthony P. Zook | ||
| /s/ Jeffrey S. Sherman | Chief Financial Officer (Principal Financial Officer) | February 17, 2026 |
| Jeffrey S. Sherman | ||
| /s/ Greg D. Aunan | Senior Vice President & Chief Accounting Officer(Principal Accounting Officer) | February 17, 2026 |
| Greg D. Aunan | ||
| /s/ Lynn A. Tetrault | Chair of the Board | February 17, 2026 |
| Lynn A. Tetrault | ||
| /s/ Marjorie C. Green | Director | February 17, 2026 |
| Marjorie C. Green | ||
| /s/ Dr. Neil Gunn | Director | February 17, 2026 |
| Dr. Neil Gunn | ||
| /s/ John P. Kenny | Director | February 17, 2026 |
| John P. Kenny | ||
| /s/ Stephen M. Kanovsky | Director | February 17, 2026 |
| Stephen M. Kanovsky | ||
| /s/ Michael A. Kelly | Director | February 17, 2026 |
| Michael A. Kelly | ||
| /s/ Felicia Williams | Director | February 17, 2026 |
| Felicia Williams | ||
| /s/ David B. Perez | Director | February 17, 2026 |
| David B. Perez | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.